ArticleCancer letters2015

Simultaneous suppression of the MAP kinase and NF-κB pathways provides a robust therapeutic potential for thyroid cancer.

Koji Tsumagari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.